Number of Shares of Sample Clauses

Number of Shares of. Common Stock Offered by Kindred: 5,000,000 shares (or 5,750,000 shares if the underwriters of the Common Stock Offering exercise their over-allotment option to purchase 750,000 additional shares in full). Last Reported Sale Price of the Common Stock on the NYSE on the Pricing Date: $19.76 per share of Common Stock. Common Stock Public Offering Price: $19.75 per share $98,750,000 in aggregate (or $113,562,500 if the underwriters of the Common Stock Offering exercise their over-allotment option to purchase 750,000 additional shares in full). Underwriting Discount: $0.839375 per share $4,196,875 in aggregate (or $4,826,406 if the underwriters of the Common Stock Offering exercise their option to purchase 750,000 additional shares in full). Estimated Net Proceeds to Kindred from the Common Stock Offering: Estimated net proceeds from the sale of Common Stock by Kindred in the Common Stock Offering, after deducting underwriting discounts and commissions, will be approximately $94.5 million (or approximately $108.7 million if the underwriters of the Common Stock Offering exercise their over-allotment option to purchase 750,000 additional shares in full). Stabilizing Transactions: Prior to purchasing the Common Stock being offered pursuant to the Common Stock Preliminary Prospectus Supplement, on November 19, 2014, one of the underwriters purchased, on behalf of the syndicate, 329,371 shares of Common Stock at an average price of $19.75 per share in stabilizing transactions. Book-Running Managers: Citigroup Global Markets Inc. X.X. Xxxxxx Securities LLC Guggenheim Securities, LLC Xxxxxx Xxxxxxx & Co. LLC Co-Managers: BMO Capital Markets Corp. Deutsche Bank Securities Inc. SunTrust Xxxxxxxx Xxxxxxxx, Inc. Units Offering Issuer: Kindred. Pricing Date: November 19, 2014. Settlement Date: November 25, 2014. Title of Securities: 7.50% Tangible Equity Units (the “Units”). Number of Units Offered: 150,000 Units (or 172,500 Units if the underwriters of the Units Offering exercise their over-allotment option to purchase 22,500 additional Units in full).
Sample 1Sample 2
AutoNDA by SimpleDocs
Number of Shares of. Common Stock: 1 1,620,000 Award Date: August 8, 2011 Exercise Price per Share: 1 $ Expiration Date: 1, 2 Ten years from grant Vesting 1,2,3 Twenty-five percent (25%) of the total number of shares of Common Stock subject to the Option shall vest on the six (6) month anniversary of the Award Date. Twenty-five percent (25%) of the total number of shares of Common Stock subject to the Option shall vest on the eighteen (18) month anniversary of the Award Date. Twenty-five percent (25%) of the total number of shares of Common Stock subject to the Option shall vest on the thirty (30) month anniversary of the Award Date. The remaining twenty-five percent (25%) of the total number of shares of Common Stock subject to the Option shall vest as of July 1, 2015 if, as of such date, either (i) the Common Stock shall have been trading above $1.10 per share and shall have closed above $1.10 per share for ten (10) of the twenty (20) trading days immediately preceding July 1, 2015; or (ii) the “weighted average trading price” for the ten (10) day period immediately preceding July 1, 2015 averages or exceeds $1.10. For purposes of this Option Agreement, the “weighted average trading price” is equal to the greater of: (1) the sum of the product of the number of shares traded each day in the period multiplied by the purchase price of such shares, with such sum divided by the total number of shares traded during such period; or (2) the amount determined under Bloomberg’s “VWSP” Calculation function. In the event the Corporation does not renew Grantee’s Employment Agreement as of January 1, 2014, then, notwithstanding the previous sentence, the remaining twenty-five percent (25%) of the total number of shares of Common Stock subject to the Option shall vest as of January 1, 2014 if the Common Stock shall have had a closing price at or above $1.00 on December 31, 2013 and for ten (10) of the twenty (20) trading days immediately preceding December 31, 2013. If the Corporation offers to renew Grantee’s Employment Agreement on or before January 1, 2014 on the same or similar terms and conditions, but Grantee declines such offer, then Grantee’s rights to the remaining twenty-five percent (25%) of the total number of shares of Common Stock subject to the Option shall be forfeited.
Sample 1
Number of Shares of. Common Stock Subject to the Option: ____________________________ Exercise Price (per share): ____________________________ Date of Grant: ____________________________ Date of Termination: ____________________________ The Option is: [ ] a Nonqualified Stock Option [ ] an Incentive Stock Option
Sample 1
Number of Shares of. Amount Beneficially Owned(1)
Sample 1
Number of Shares of. Common Stock Outstanding: 2,713,636 shares
Sample 1
Number of Shares of. Common Stock owned today subject to a Lock-up Period (including any shares remaining under the Initial Registration Statement that have not been sold and are held at the transfer agent or in a restricted broker account)
Sample 1
AutoNDA by SimpleDocs
Number of Shares of. Non- Non- Weighted Incentive Statutory Qualified Average Stock Stock Options to Exercise Options Options Directors Price ------- ------- --------- ----- Options Reserved in Conversion................. 608,505 216,390 210,105 $ 10.00 ======= ======= ======= ======= Balance Outstanding at June 30, 1994........... 608,505 216,390 196,650 $ 10.00 Granted........................................ -- -- -- -- Forfeited...................................... -- -- -- Exercised...................................... -- -- -- -- -------- ------- ------- ------ Balance Outstanding at June 30, 1995........... 608,505 216,390 196,650 10.00 Granted........................................ -- -- 6,727 15.25 Forfeited...................................... -- -- -- -- Exercised...................................... -- -- -- -- -------- ------- ------- ------ Balance Outstanding at June 30, 1996........... 608,505 216,390 203,377 10.03 Granted........................................ 70,398 213,402 40,500 18.22 Forfeited...................................... -- -- -- -- Exercised...................................... (48,780) (35,000) (6,000) 10.00 -------- ------- ------- ------ Balance Outstanding at June 30, 1997........... 630,123 394,792 237,877 $ 11.96 ======= ======= ======= ======= Shares Exercisable at June 30, 1997............ 353,860 144,897 233,392 $ 11.02 ======= ======= ======= ======= Had compensation cost for the Company's three stock-based compensation plans been determined consistent with SFAS No. 123 for awards made after July 1, 1995, the Company's net income per common share would have been reduced to the pro forma amounts indicated below for the years ended June 30: 1997 1996 ---- ---- (Dollars in thousands, except per share data) Net Income As Reported $10,936 $11,723 Pro forma 8,672 11,669 Net Income per Common Share: Primary As Reported $1.24 $1.31 Pro forma 0.98 1.31
Sample 1

Related to Number of Shares of

  • Number of Shares This Warrant shall be exercisable for the Initial Shares, plus the Additional Shares, if any (collectively, and as may be adjusted from time to time pursuant to the provisions of this Warrant, the “Shares”).

  • Number of Shares; Exercise Price This certifies that, for value received, Cede & Co., and any of its registered assigns, is the registered owner of the number of Warrants set forth on Schedule A hereto, each of which entitles the Warrantholder to purchase from the Company, upon the terms and subject to the conditions hereinafter set forth, a number of fully paid and nonassessable shares of Common Stock (each a “Share” and collectively the “Shares”) equal to the Warrant Share Number at a purchase price per share equal to the Exercise Price. The Warrant Share Number and the Exercise Price are subject to adjustment as provided herein, and all references to “Warrant Share Number” and “Exercise Price” herein shall be deemed to include any such adjustment or series of adjustments.

  • NUMBER OF SHARES AND EXERCISE PRICE The number of shares of Common Stock subject to your option and your exercise price per share referenced in your Grant Notice may be adjusted from time to time for Capitalization Adjustments.

  • Maximum Number of Shares Under no circumstances shall the Company cause or request the offer or sale of any Shares if, after giving effect to the sale of such Shares, the aggregate amount of Shares sold pursuant to this Agreement would exceed the lesser of (A) together with all sales of Shares under this Agreement, the Maximum Amount, (B) the amount available for offer and sale under the currently effective Registration Statement and (C) the amount authorized from time to time to be issued and sold under this Agreement by the Board, a duly authorized committee thereof or a duly authorized executive committee, and notified to the Manager in writing. Under no circumstances shall the Company cause or request the offer or sale of any Shares pursuant to this Agreement at a price lower than the minimum price authorized from time to time by the Board, a duly authorized committee thereof or a duly authorized executive officer, and notified to the Manager in writing. Further, under no circumstances shall the Company cause or permit the aggregate offering amount of Shares sold pursuant to this Agreement to exceed the Maximum Amount.

  • Adjustment of Exercise Price, Number of Shares or Number of Rights The Exercise Price, the number and kind of shares or other property covered by each Right and the number of Rights outstanding are subject to adjustment from time to time as provided in this Section 11.

  • Adjustment in Number of Shares Upon each adjustment of the Exercise Price pursuant to the provisions of this Paragraph 4, the number of shares of Common Stock issuable upon exercise of this Warrant shall be adjusted by multiplying a number equal to the Exercise Price in effect immediately prior to such adjustment by the number of shares of Common Stock issuable upon exercise of this Warrant immediately prior to such adjustment and dividing the product so obtained by the adjusted Exercise Price.

  • Adjustment to Number of Shares Upon each adjustment of the Exercise Price, the number of Shares issuable upon exercise of the Warrant shall be increased to equal the quotient obtained by dividing (x) the product resulting from multiplying (i) the number of Shares issuable upon exercise of the Warrant, and (ii) the Exercise Price, in each case as in effect immediately before such adjustment by (y) the adjusted Exercise Price.

  • Number of Shares Issuable upon Exercise From and after the Issue Date through and including the Expiration Date, the Holder hereof shall be entitled to receive, upon exercise of this Warrant in whole in accordance with the terms of subsection 1.2 or upon exercise of this Warrant in part in accordance with subsection 1.3, shares of Common Stock of the Company, subject to adjustment pursuant to Section 4.

  • Purchase Price; Number of Shares (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 (the “Purchase Price”), 185,714 fully paid and nonassessable shares of the Company’s Series D Preferred Stock, (the “Exercise Quantity”), $0.001 par value (the “Preferred Stock”).

  • Adjustment of Number of Shares Upon each adjustment in the Warrant Price, the number of Shares purchasable hereunder shall be adjusted, to the nearest whole share, to the product obtained by multiplying the number of Shares purchasable immediately prior to such adjustment in the Warrant Price by a fraction, the numerator of which shall be the Warrant Price immediately prior to such adjustment and the denominator of which shall be the Warrant Price immediately thereafter.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!